NL-OMON32922已完成4 期
Pharmacokinetics of anidulafungin in critically ill patients with invasive candidiasis - Pharmacokinetics of anidulafungin
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •treatment with anidulafungin
- •at least 18 years of age
- •invasive canidiasis
- •admitted to an intensive care unit
排除标准
- •allergic to anidulafungin or its excipients
- •contra-indication stated in IB1-brochure
- •neutropenia
研究者
相似试验
进行中（未招募）
不适用
The pharmacokinetics of anidulafungin during continuous venovenous hemofiltratiointensive care patients with suspected or proven fungal infection, who undergo hemofiltrationMedDRA version: 9.1Level: LLTClassification code 10042941Term: Systemic fungal infection NOSEUCTR2008-007753-12-ATMUW, Universitätsklinik für Innere Medizin I, Abteilung für Infektionskrankheiten und Tropenmedizin
已完成
不适用
Pharmacokinetics of Anidulafungin on Intensive Care Unit (ICU)Invasive CandidiasisCritically IllNCT01047267University Medical Center Groningen20
进行中（未招募）
不适用
Farmacocinética de anidulafungina en pacientes sometidos a hemodiafiltración.Tratamiento de candidiasis Invasiva en paciente adulto no neutropenico.MedDRA version: 13Level: LLTClassification code 10042938EUCTR2010-024457-36-ESDr.Gerardo Aguilar Dr.Francisco Martí Hospital Clínico de Valencia Ser. Anestesiología y Reanimación
已完成
4 期
Anidulafungin pharmacokinetics given as a single intravenous dose to obese patients (ADOPT).Candidiasis / Fungal infections10017528NL-OMON40398niversitair Medisch Centrum Sint Radboud8
Unknown
不适用
Anidulafungin Pharmacokinetics in Intensive Care Unit PatientsInvasive CandidiasisCandidemiaNCT01438216Amsterdam UMC, location VUmc20